ADC Therapeutics SA (ADCT) Total liabilities 2022–2025
ADC Therapeutics SA (ADCT) total liabilities at each fiscal year-end, per SEC filings.
$509.0MFY2025 · since FY2022: $411.4M → $509.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $509.0M | -3.0% |
| FY2024 | $524.6M | +4.3% |
| FY2023 | $503.0M | +22.3% |
| FY2022 | $411.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Net marginADCT Gross profitADCT Gross marginADCT Operating incomeADCT Operating marginADCT Operating cash flowADCT Free cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Shareholders’ equityADCT overview →